# Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

> **NCT01037114** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis A
- Hepatitis B

## Interventions

- **PROCEDURE:** Blood sampling
- **BIOLOGICAL:** Engerix-B
- **BIOLOGICAL:** Havrix

## Key facts

- **NCT ID:** NCT01037114
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-27
- **Primary completion:** 2014-02-28
- **Final completion:** 2014-02-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037114, "Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01037114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*